Track funded life science companies, founders and investors across the UK startup ecosystem.
| Date | Startup | Funding | Round | Sector | Location | Connect | Website | Investor1 | Investor2 | Investor3 | Investor4 | Investor5 | Founder(s) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
24 Sept 2026 | Basecamp Research Basecamp Research offers a drug discovery platform that combines genetic da... | £105,630,000 US$140,000,000 | |||||||||||
24 Sept 2026 | IMS Solutions ACCelerate is a urine diagnostic test that measures steroid biomarkers and ... | £1,100,000 | |||||||||||
22 Sept 2026 | SageTech Medical SageTech Medical supplies a recycling system for waste anaesthetic in hospi... | £2,500,000 | Devon | ||||||||||
18 Sept 2026 | Big Picture Bio Big Picture Bio provides a platform that uses AI to model disease and propo... | £1,500,000 | |||||||||||
17 Sept 2026 | Chemify Chemify provides an automated chemistry discovery platform combining labora... | £22,000,000 | |||||||||||
17 Sept 2026 | MicroLub A protein-based ingredient that replaces fat's lubricating role with water ... | £7,500,000 | Leeds | ||||||||||
17 Sept 2026 | Eterna Regeneratives A keratin scaffold that forms a thin layer on tooth and bone surfaces. It i... | ||||||||||||
16 Sept 2026 | Axo Longevity Axo Longevity is a membership service that provides regular blood panels, a... | £3,710,000 US$5,000,000 | |||||||||||
15 Sept 2026 | Athernal Bio Athernal Bio develops targeted immunotherapies that recognise and remove hi... | £700,000 | |||||||||||
15 Sept 2026 | Magnitude Biosciences VivoScan is a platform that tests chemical compounds in living C. elegans u... | £1,300,000 | Durham | ||||||||||
15 Sept 2026 | Fuse Diagnostics Flip is an instrument-free molecular diagnostics platform combining proprie... | £1,000,000 | |||||||||||
14 Sept 2026 | Bitrobius Genetics Gentrafix is a plasmid-based platform that replicates in human cells and sp... | £700,000 | Cheshire | ||||||||||
9 Sept 2026 | ViaNautis polyNaut® is a non-viral delivery platform that uses targeted polymer nanov... | €20,000,000 | |||||||||||
9 Sept 2026 | Anemo Labs Anemo Labs makes a sensor device that samples urine and analyses scent usin... | £700,000 | |||||||||||
1 Sept 2026 | Healome Therapeutics Healome Therapeutics develops biomaterial scaffolds for clinical tissue rep... | ||||||||||||
10 Aug 2026 | Mironid Mironid develops oral small-molecule LoAc compounds that target cAMP signal... | £34,110,000 US$46,000,000 | |||||||||||
29 Jul 2026 | Qureight Qureight offers an AI imaging platform that combines imaging services with ... | £15,000,000 | |||||||||||
14 Jul 2026 | Draig Therapeutics DT-101 is an AMPA receptor potentiator and positive allosteric modulator. I... | £48,640,000 US$65,000,000 | Cardiff | ||||||||||
10 Jul 2026 | Alchemab Therapeutics Resiliome is a platform that combines deep sequencing of antibodies with a ... | £25,000,000 | |||||||||||
9 Jul 2026 | Respiro Diagnostics Respiro Diagnostics supplies a breath-based liquid biopsy system that colle... | £1,000,000 | |||||||||||
6 Jul 2026 | Revolver Therapeutics Revolver Therapeutics provides a discovery platform and peptide therapeutic... | £572 | Bath | ||||||||||
30 Jun 2026 | Neuronostics BioEP is an EEG-based biomarker platform that analyses routine EEG recordin... | £3,000,000 | |||||||||||
24 Jun 2026 | RQ Bio RQB01 is a long-acting monoclonal antibody candidate developed to provide s... | £87,090,000 US$115,000,000 | |||||||||||
23 Jun 2026 | Astral Systems Astral Systems supplies modular Multi-State Fusion reactors designed as com... | £23,000,000 | |||||||||||
23 Jun 2026 | TRIMTECH Therapeutics TRIMTECH Therapeutics develops proprietary small-molecule degrader platform... | £11,000,000 | |||||||||||
23 Jun 2026 | LabCycle LabCycle's AutoDecon is a system that cleans and processes single-use labor... | £180,000 | |||||||||||
22 Jun 2026 | Houdini Bio Houdini Bio offers a machine learning-guided DNA sequence design platform f... | £1,500,000 | |||||||||||
10 Jun 2026 | 01Health 01Health provides a clinic-facing digital platform that bundles scheduling,... | £11,210,000 US$15,000,000 | |||||||||||
2 Jun 2026 | IMU Bioscience IMU Bioscience offers a clinical platform that performs multi-omic analysis... | £39,390,000 US$53,000,000 | |||||||||||
2 Jun 2026 | Hexigone Hexigone provides a responsive additive that integrates into protective coa... | £1,200,000 | Swansea |

1 Explore 246 UK life science startups and their founders, who have collectively raised £6.25B.
2 Easily sort, filter, and compare the UK's top startups — customise the list to your needs.
3 Discover top startups for investment, B2B sales, partnerships, hiring, and industry connections.
You can connect with fast-growing life science startups with the full list of recently funded startups from the UK.
With UK-based startups such as Exscientia, BenevolentAI, and Healx, the UK's life sciences sector has rapidly emerged as a hub for innovative healthcare solutions. Driven by advancements in biotechnology, artificial intelligence, and personalised medicine, life science startups are transforming approaches to drug discovery, diagnostics, and patient care.
Life science startups are companies that focus on developing technologies and solutions to advance healthcare, medicine, and biological research. They operate at the intersection of biology and technology, aiming to address complex challenges in health and disease through innovative approaches.
These startups often leverage cutting-edge technologies such as artificial intelligence, machine learning, and genomics to accelerate drug discovery, improve diagnostic accuracy, and personalise treatment plans. By integrating multidisciplinary expertise, they contribute to the development of novel therapies, medical devices, and healthcare platforms.
With substantial funding and support from the scientific community and life science investors, the ecosystem continues to expand rapidly. Let’s explore the key areas currently driving innovation within life science startups:
Life science startups in the UK are pioneering advancements across various domains by harnessing technological innovations and scientific research. Here are five distinct categories of life science startups:
Companies utilising artificial intelligence to streamline the drug discovery process, reducing time and costs associated with bringing new medications to market (examples: Exscientia, BenevolentAI).
Startups focusing on tailoring medical treatments to individual patients based on genetic, environmental, and lifestyle factors, enhancing treatment efficacy and reducing adverse effects (examples: Healx, Congenica).
Companies developing advanced tools and platforms to support biological research and development, facilitating breakthroughs in understanding diseases and developing new therapies (examples: Sphere Fluidics, Oxford Nanopore Technologies).
Startups creating digital solutions to improve patient care, enhance healthcare delivery, and enable remote monitoring and consultations (examples: Cera Care, Babylon Health).
Companies specialising in developing diagnostic tests and identifying biomarkers for early detection and monitoring of diseases, improving patient outcomes through timely intervention (examples: Dxcover, Mologic).